HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

Twenty-four-hour intraocular pressure control with the travoprost/timolol maleate fixed combination compared with travoprost when both are dosed in the evening in primary open-angle glaucoma.

AbstractOBJECTIVE:
To evaluate the 24 h efficacy and safety of the travoprost/timolol maleate fixed combination (TTFC) versus travoprost when both are dosed in the evening in primary open-angle glaucoma patients.
METHODS:
Prospective, double-masked, crossover, active-controlled, randomised 24 h comparison. After a 6 week medicine-free period, patients were randomised to either TTFC or travoprost for 8 weeks and were then switched to the opposite treatment for another 8 weeks. At the end of the washout and treatment periods, a 24 h pressure curve was performed.
RESULTS:
Thirty-two patients completed the study. The TTFC group demonstrated a lower absolute intraocular pressure level (2.4 mm Hg) for the 24 h curve and at all time points, compared with travoprost (p</=0.047). The pressure reduction from untreated baseline was significantly different between treatments for all time points (p = 0.018). The mean 24 h pressure fluctuation was lower with TTFC (3.0 mm Hg) compared with travoprost (4.0 mm Hg, p = 0.001). No statistical difference existed between the two treatment groups for any adverse event (p>0.05).
CONCLUSIONS:
This study suggests that when both drugs are dosed in the evening the TTFC provides improved intraocular pressure reduction, compared with travoprost, over the 24 h curve and for each individual time point in primary open-angle glaucoma patients.
AuthorsA G P Konstas, D Mikropoulos, A-B Haidich, K S Ntampos, W C Stewart
JournalThe British journal of ophthalmology (Br J Ophthalmol) Vol. 93 Issue 4 Pg. 481-5 (Apr 2009) ISSN: 1468-2079 [Electronic] England
PMID19019932 (Publication Type: Journal Article, Randomized Controlled Trial, Research Support, Non-U.S. Gov't)
Chemical References
  • Antihypertensive Agents
  • Drug Combinations
  • Cloprostenol
  • Timolol
  • Travoprost
Topics
  • Adult
  • Aged
  • Antihypertensive Agents (administration & dosage, adverse effects)
  • Circadian Rhythm
  • Cloprostenol (administration & dosage, adverse effects, analogs & derivatives)
  • Cross-Over Studies
  • Double-Blind Method
  • Drug Administration Schedule
  • Drug Combinations
  • Female
  • Glaucoma, Open-Angle (drug therapy, physiopathology)
  • Humans
  • Intraocular Pressure (drug effects)
  • Male
  • Middle Aged
  • Timolol (administration & dosage, adverse effects)
  • Travoprost
  • Treatment Outcome

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.
Realize the full power of the drug-disease research graph!


Choose Username:
Email:
Password:
Verify Password:
Enter Code Shown: